Functional characterization and expression profiling of human induced pluripotent stem cell- and embryonic stem cell-derived endothelial cells

Stem Cells and Development

Volumn 20, Issue 10, 2011, Pages 1701-1710

  Li, Zongjin ^a,b   Hu, Shijun ^a   Ghosh, Zhumur ^a,c   Han, Zhongchao ^d   Wu, Joseph C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NANKAI UNIVERSITY   (China)

^c BOSE INSTITUTE   (India)

^d INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; MATRIGEL;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL SELECTION; CELL STRUCTURE; EMBRYOID BODY; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; FLUORESCENCE ANALYSIS; GENE EXPRESSION; GENETIC VARIABILITY; GENOME; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MORPHOGENESIS; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL SHAPE; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 80053412471     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2010.0426     Document Type: Article

References (37)

1. Thomson JA, J Itskovitz-Eldor, SS Shapiro, MA Waknitz, JJ Swiergiel, VS Marshall and JM Jones. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147. (Pubitemid 28516247)
2. Yu J, MA Vodyanik, K Smuga-Otto, J Antosiewicz-Bourget, JL Frane, S Tian, J Nie, GA Jonsdottir, V Ruotti, R Stewart, Slukvin, II and JA Thomson. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
3. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872. (Pubitemid 350138099)
4. Soldner F, D Hockemeyer, C Beard, Q Gao, GW Bell, EG Cook, G Hargus, A Blak, O Cooper, M Mitalipova, O Isacson and R Jaenisch. (2009). Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136:964-977.
5. Ye L, JC Chang, C Lin, X Sun, J Yu and YW Kan. (2009). Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc Natl Acad Sci U S A 106:9826-9830.
6. Choi KD, J Yu, K Smuga-Otto, G Salvagiotto,WRehrauer, M Vodyanik, J Thomson and I Slukvin. (2009). Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 27:559-567.
7. Feng Q, SJ Lu, I Klimanskaya, I Gomes, D Kim, Y Chung, GR Honig, KS Kim and R Lanza. (2010). Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 28:704-712.
8. Zhang J, GF Wilson, AG Soerens, CH Koonce, J Yu, SP Palecek, JA Thomson and TJ Kamp. (2009). Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104:e30-e41.
9. Stadtfeld M, and K Hochedlinger. (2010). Induced pluripotentcy: history, mechanisms, and applications. Genes Dev 24:2239-2263.
10. Li Z, Y Suzuki, M Huang, F Cao, X Xie, AJ Connolly, PC Yang and JC Wu. (2008). Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells 26:864-873.
11. Li Z, KD Wilson, B Smith, DL Kraft, F Jia, M Huang, X Xie, RC Robbins, SS Gambhir, IL Weissman and JC Wu. (2009). Functional and transcriptional characterization of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction. PLoS One 4:e8443.
12. Ueland J, A Yuan, A Marlier, AR Gallagher and A Karihaloo.(2009). A novel role for the chemokine receptor Cxcr4 inkidney morphogenesis: an in vitro study. Dev Dyn 238:1083-1091.
13. Su W, M Zhou, Y Zheng, Y Fan, L Wang, Z Han, D Kong, RC Zhao, JC Wu, R Xiang and Z Li. (2010). Bioluminescence reporter gene imaging characterize human embryonic stem cell-derived teratoma formation. J Cell Biochem [Epub ahead of print]; DOI:10.1002/jcb.22982.
14. Li ZJ, ZZ Wang, YZ Zheng, B Xu, RC Yang, DT Scadden and ZC Han. (2005). Kinetic expression of platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) during embryonic stem cell differentiation. J Cell Biochem 95:559-570. (Pubitemid 41420185)
15. Chen T, H Bai, Y Shao, M Arzigian, V Janzen, E Attar, Y Xie, DT Scadden and ZZ Wang. (2007). Stromal cell-derived factor-1/CXCR4 signaling modifies the capillary-like organization of human embryonic stem cell-derived endothelium in vitro. Stem Cells 25:392-401. (Pubitemid 46232794)
16. Lin HT, CL Kao, KH Lee, YL Chang, SH Chiou, FT Tsai, TH Tsai, DC Sheu, LL Ho and HH Ku. (2007). Enhancement of insulin-producing cell differentiation from embryonic stem cells using pax4-nucleofection method. World J Gastroenterol 13:1672-1679. (Pubitemid 46711337)
17. Yamashita J, H Itoh, M Hirashima, M Ogawa, S Nishikawa, T Yurugi, M Naito, K Nakao and S Nishikawa. (2000). Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408:92-96.
18. Malinda KM. (2003). In vivo matrigel migration and angiogenesis assays. Methods Mol Med 78:329-335.
19. Wang ZZ, P Au, T Chen, Y Shao, LM Daheron, H Bai, M Arzigian, D Fukumura, RK Jain and DT Scadden. (2007). Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat Biotechnol 25:317-318. (Pubitemid 46398769)
20. Levenberg S, JS Golub, M Amit, J Itskovitz-Eldor and R Langer. (2002). Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 99:4391-4396. (Pubitemid 34285995)
21. Yang C, ZH Zhang, ZJ Li, RC Yang, GQ Qian and ZC Han. (2004). Enhancement of neovascularization with cord blood CD133 + cell-derived endothelial progenitor cell transplantation. Thromb Haemost 91:1202-1212. (Pubitemid 38821278)
22. Gupta SK, T Hassel and JP Singh. (1995). A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4. Proc Natl Acad Sci U S A 92:7799-7803.
23. Fischer A, N Schumacher, M Maier, M Sendtner and M Gessler. (2004). The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev 18:901-911. (Pubitemid 38529659)
24. Lee CY, KM Vogeli, SH Kim, SW Chong, YJ Jiang, DY Stainier and SW Jin. (2009). Notch signaling functions as a cell-fate switch between the endothelial and hematopoietic lineages. Curr Biol 19:1616-1622.
25. Lee SS, YM Kim, E Junn, G Lee, KH Park, M Tanaka, RD Ronchetti, MM Quezado and MM Mouradian. (2003). Cell cycle aberrations by alpha-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies. Neurobiol Aging 24:687-696. (Pubitemid 37303989)
26. Huang P. (2010). HDAC5: going with the flow. Blood 115:2728-2729.
27. Song MB, XJ Yu, GX Zhu, JF Chen, G Zhao and L Huang. (2009). Transfection of HGF gene enhances endothelial progenitor cell (EPC) function and improves EPC transplant efficiency for balloon-induced arterial injury in hypercholesterolemic rats. Vascul Pharmacol 51:205-213.
28. Ding Z, A Lambrechts, M Parepally and P Roy. (2006). Silencing profilin-1 inhibits endothelial cell proliferation, migration and cord morphogenesis. J Cell Sci 119:4127-4137. (Pubitemid 44650884)
29. Gomez D and NC Reich. (2003). Stimulation of primary human endothelial cell proliferation by IFN. J Immunol 170:5373-5381. (Pubitemid 36617822)
30. Qiao M, P Shapiro, M Fosbrink, H Rus, R Kumar and A Passaniti. (2006). Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation. J Biol Chem 281:7118-7128. (Pubitemid 43847476)
31. Bernatchez PN, S Rollin, S Soker and MG Sirois. (2002). Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: role of neuropilin-1. J Cell Biochem 85:629-639. (Pubitemid 34465143)
32. Jozefczuk J, A Prigione, L Chavez and J Adjaye. (2011). Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation. Stem Cells Dev [Epub ahead of print]; DOI:10.1089/scd.2010.0361.
33. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676. (Pubitemid 44233629)
34. Sun N, MT Longaker and JC Wu. (2010). Human iPS cellbased therapy: considerations before clinical applications. Cell Cycle 9:880-885.
35. Ghosh Z, KD Wilson, Wu Y, S Hu, T Quertermous, JC Wu. (2010). Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS One 5:e8975.
36. Stadtfeld M, E Apostolou, H Akutsu, A Fukuda, P Follett, S Natesan, T Kono, T Shioda and K Hochedlinger. (2010). Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465:175-181.
37. Urbach A, O Bar-Nur, GQ Daley and N Benvenisty. (2010). Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 6:407-411.